Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients

Matrix metalloproteinas-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease

(2011) Massoud Saedi et al.   MOLECULAR BIOLOGY REPORTS

Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study

(2011) Wojciech Plazak et al.   ARTHRITIS RESEARCH & THERAPY

MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease

(2010) Xiaobo Gai et al.   CLINICA CHIMICA ACTA

The Role of Matrix Metalloproteinase-2 Promoter Polymorphisms in Coronary Artery Disease and Myocardial Infarction

(2010) Ebru Alp et al.   Genetic Testing and Molecular Biomarkers

Rosuvastatin Inhibits MMP-2 Expression and Limits the Progression of Atherosclerosis in LDLR-deficient Mice

(2009) Hangyuan Guo et al.   ARCHIVES OF MEDICAL RESEARCH

Butyrylcholinesterase K variant and the APOE-ε4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients

(2009) Asad Vaisi-Raygani et al.   MOLECULAR BIOLOGY REPORTS

Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus

(2008) Yih-Hsin Chang et al.   CLINICAL BIOCHEMISTRY

Dissociation of neopterin and 7,8-dihydroneopterin from plasma components before HPLC analysis

(2008) Elizabeth A. Flavall et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

The regulation of matrix metalloproteinases and their inhibitors

(2007) I CLARK et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY